Viatris Inc. (VTRS) has been a common name in various securities
fraud lawsuits recently with multiple law firms such as
Schall Law Firm,
Berger Montague, Levi & Korsinsky, urging investors to act before the deadline of June 3, 2025. Given the number of such lawsuits, even investors who lost money have opportunities to lead some of these cases. On a positive note, Viatris has announced achievement in the biotech industry with promising
Phase 3 Study results of an investigational low dose patch for birth control in women,
XULANE LO™. Additionally, compelling financial results of FY 2024 and Q1 2025 have been shared with a reaffirmation on 2025 outlook. Adding, Viatris has announced the appointment of
Scott A. Smith as CEO effective from April 1, 2023, and revealed news about agreements on remaining planned divestitures.
Viatris VTRS News Analytics from Mon, 27 Feb 2023 08:00:00 GMT to Fri, 23 May 2025 20:01:06 GMT -
Rating -5
- Innovation -2
- Information 8
- Rumor 2
